Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Tuberous Sclerosis Complex-associated Refractory Seizures
×
Everolimus
×
Clear all
Filters
3
NCT01713946
2018-11-07
EXIST-3
Novartis
Phase 3
Completed
366 enrolled
38 charts
1 FDA